The DOI matches its Crossref record; 312 of the 312 references it cites were found in a registry or an index.
ACG Clinical Guideline: Management of Crohn's Disease in Adults
Abstract
Crohn's disease is an idiopathic inflammatory disorder of unknown etiology with genetic, immunologic, and environmental influences. The incidence of Crohn's disease has steadily increased over the past several decades. The diagnosis and treatment of patients with Crohn's disease has evolved since the last practice guideline was published. These guidelines represent the official practice recommendations of the American College of Gastroenterology and were developed under the auspices of the Practice Parameters Committee for the management of adult patients with Crohn's disease. These guidelines are established for clinical practice with the intent of suggesting preferable approaches to particular medical problems as established by interpretation and collation of scientifically valid research, derived from extensive review of published literature. When exercising clinical judgment, health-care providers should incorporate this guideline along with patient's needs, desires, and their values in order to fully and appropriately care for patients with Crohn's disease. This guideline is intended to be flexible, not necessarily indicating the only acceptable approach, and should be distinguished from standards of care that are inflexible and rarely violated. To evaluate the level of evidence and strength of recommendations, we used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. The Committee reviews guidelines in depth, with participation from experienced clinicians and others in related fields. The final recommendations are based on the data available at the time of the production of the document and may be updated with pertinent scientific developments at a later time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–312 of 312
Crohn’s Disease and Ulcerative Colitis Are Associated With Elevated Standardized Mortality Ratios
Bewtra, M., Kaiser, L., Tenhave, T., & Lewis, J. D. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31827f27ae · Cited by 140
Deep Remission in Inflammatory Bowel Disease: Looking Beyond Symptoms
Zallot, C., & Peyrin‐Biroulet, L. (2013) · Current Gastroenterology Reports · doi:10.1007/s11894-013-0315-7 · Cited by 140
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease
Akobeng, A. K., & Zachos, M. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003574.pub2 · Cited by 139
Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD
Carballal, S., Maisterra, S., López‐Serrano, A., Gimeno‐García, A. Z., Vera, M. I., Marín-Gabriel, J. C., Díaz-Tasende, J., Márquez, L., Álvarez, M. A., Hernández, L., et al. (2016) · Gut · doi:10.1136/gutjnl-2016-312332 · Cited by 137
Boschetti, G., Laidet, M., Moussata, D., Stéfanescu, C., Roblin, X., Phelip, G., Cotte, E., Passot, G., François, Y., Drai, J., et al. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.30 · Cited by 136
Postoperative Therapy With Infliximab Prevents Long-term Crohn’s Disease Recurrence
Regueiro, M. D., Kip, K. E., Baidoo, L., Swoger, J. M., & Schraut, W. H. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.12.035 · Cited by 136
Self-citationLennard-Jones, J. E., & Shivananda, S. (1997) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199704000-00007 · Cited by 135
Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease
Prantera, C., Pallone, F., Brunetti, G., Cottone, M., & Miglioli, M. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90822-g · Cited by 132
Yamamoto, T., Umegae, S., & Matsumoto, K. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20915 · Cited by 132
Iglesias–Rey, M., Acosta, M. B., Caamaño‐Isorna, F., Vázquez, I., Ferreiro, R., Lindkvist, B., González, A. L., & Domínguez‐Muñoz, J. E. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000436955.78220.bc · Cited by 127
de Groof, E. J., Sahami, S., Lucas, C., Ponsioen, C. Y., Bemelman, W. A., & Buskens, C. J. (2016) · Colorectal Disease · doi:10.1111/codi.13311 · Cited by 125
Oral budesonide as maintenance therapy in Crohn’s disease—results of a 12‐month study
Ferguson, Campieri, M., Doe, Persson, Nygård, & THE GLOBAL BUDESONIDE STUDY GROUP (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00285.x · Cited by 124
Sorrentino, D. R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.16.1804 · Cited by 124
Garcia, J. C., Persky, S. E., Bonis, P. A., & Topazian, M. D. (2001) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200105000-00010 · Cited by 124
Psychiatric co‐morbidity is associated with increased risk of surgery in Crohn's disease
Ananthakrishnan, A. N., Gainer, V. S., Perez, R. G., Cai, T., Cheng, S. ‐., Savova, G., Chen, P., Szolovits, P., Xia, Z., De Jager, P. L., et al. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12195 · Cited by 122
Tremaine, W. J., Hanauer, S. B., Katz, S., Winston, B., Levine, J. G., Persson, T., & Persson, A. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05835.x · Cited by 121
Feller, M., Huwiler, K., Schoepfer, A. M., Shang, A., Furrer, H., & Egger, M. (2010) · Clinical Infectious Diseases · doi:10.1086/649923 · Cited by 121
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
Chande, N., Tsoulis, D. J., & MacDonald, J. K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000545.pub4 · Cited by 121
Schwartz, D. A., White, C. M., Wise, P. E., & Herline, A. J. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000172811.57242.18 · Cited by 120
Sandborn, W. J., Löfberg, R., Feagan, B. G., Hanauer, S. B., Campieri, M., & Greenberg, G. R. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41992.x · Cited by 119
Roberts, R. L., Gearry, R. B., Hollis‐Moffatt, J. E., Miller, A. L., Reid, J., Abkevich, V., Timms, K. M., Gutin, A., Lanchbury, J. S. S., Merriman, T. R., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01525.x · Cited by 118
Gisbert, J. P., Marín, A. C., & Chaparro, M. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13276 · Cited by 118
Henderson, P., Casey, A., Lawrence, S. J., Kennedy, N. A., Kingstone, K., Rogers, P., Gillett, P. M., & Wilson, D. C. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.33 · Cited by 116
Mooiweer, E., Jong, A. E. V. D. M., Ponsioen, C. Y., Fidder, H. H., Siersema, P. D., Dekker, E., & Oldenburg, B. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.63 · Cited by 115
The efficacy of methotrexate for maintaining remission in inflammatory bowel disease
Fraser, A. G., Morton, D., McGovern, D. P. B., Travis, S. P. L., & Jewell, D. P. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01227.x · Cited by 114
Daperno, M., Castiglione, F., de Ridder, L., Dotan, I., Färkkilä, M. A., Florholmen, J., FRASER, G. M., Fries, W., Hébuterne, X., Lakatos, P. L., et al. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.07.003 · Cited by 113
Singh, S., Garg, S. K., Pardi, D. S., Wang, Z., Murad, M. H., & Loftus, E. V. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.09.031 · Cited by 113
Self-citationWinter, J., Gaffney, D., SHAPIRO, D., Spooner, R. J., Marinaki, A. M., Sanderson, J. D., & Mills, P. R. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03301.x · Cited by 112
Healing of perineal Crohn's disease with metronidazole.
Bernstein, L. H., Frank, M. S., Brandt, L. J., et al. (1980) · PubMed · Cited by 111
Does Infliximab Infusion Impact Results of Operative Treatment for Crohn's Perianal Fistulas?
Gaertner, W. B., Decanini, A., Mellgren, A. F., Lowry, A. C., Goldberg, S. M., Madoff, R. D., & Spencer, M. P. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-9077-3 · Cited by 111
Cortot, A., Colombel, J.-F., Rutgeerts, P., Lauritsen, K., Malchow, H., Hämling, J., Winter, T. A., Gossum, A. V., Persson, T., & Pettersson, E. (2001) · Gut · doi:10.1136/gut.48.2.186 · Cited by 110
Khanna, R., Zou, G., D’Haens, G., Rutgeerts, P. J., McDonald, J. W. D., Daperno, M., Feagan, B. G., Sandborn, W. J., Dubcenco, E., Stitt, L., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308973 · Cited by 110
Aminosalicylates for induction of remission or response in Crohn's disease
Lim, W. C., & Hanauer, S. B. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008870 · Cited by 110
Papamichael, K., Archavlis, E. J., Lariou, C., & Mantzaris, G. J. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.02.012 · Cited by 109
Ford, A. C., Khan, K. J., Talley, N. J., & Moayyedi, P. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.317 · Cited by 108
A meta-analysis of antimycobacterial therapy for Crohn's disease
Borgaonkar, M. R., MacIntosh, D. G., & Fardy, J. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01842.x · Cited by 107
Gross, V., Andus, T., Ecker, K. W., Raedler, A., Loeschke, K., Plauth, M., Rasenack, J. W. F., Weber, A., Gierend, M., Ewe, K., et al. (1998) · Gut · doi:10.1136/gut.42.4.493 · Cited by 107
Budesonide in the treatment of Crohn’s disease: a meta‐analysis
Papi, C., Luchetti, R., Gili, L., Montanti, S., Koch, M., & Capurso, L. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00867.x · Cited by 106
Lunney, P. C., Kariyawasam, V. C., Wang, R. R., Middleton, K., Huang, T., Selinger, C. P., Andrews, J. M., Katelaris, P., & Leong, R. W. L. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13239 · Cited by 104
Spradlin, N. M., Wise, P. E., Herline, A. J., Muldoon, R. L., Rosen, M. J., & Schwartz, D. A. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02063.x · Cited by 104
Yang, Z., Clark, N., & Park, K. T. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.06.028 · Cited by 104
High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment
Magro, F., Rodrigues‐Pinto, E., Santos‐Antunes, J., Boas, F. V., Lopes, S., Nunes, A. C. R., Dias, C. C., & Macedo, G. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.07.005 · Cited by 104
Meta‐analysis: diagnostic medical radiation exposure in inflammatory bowel disease
Chatu, S. S., Subramanian, V., & Pollok, R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04975.x · Cited by 100
Molander, P., Färkkilä, M. A., Ristimaki, A. P., Salminen, K., Kemppainen, H., Blomster, T., Koskela, R., Jussila, A., Rautiainen, H., Nissinen, M. J., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.06.012 · Cited by 100
Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
Steinhart, A. H., Hemphill, D. J., & Greenberg, G. R. (1994) · PubMed · Cited by 100
Hinojosa, J., Gomollón, F., GARCÍA, S., Bastida, G., Cabriada, J. L., Saro, C. M., CEBALLOS, D. S., Peñate, M., Gassull, M. À., & ON BEHALF OF GETECCU GRUPO ESPAÑOL DE TRABAJO PARA EL ESTUDIO DE E. CROHN Y COLITIS ULCEROSA (SPANISH SCIENTIFIC GROUP ON CROHN'S DISEASE AND ULCERATIVE COLITIS) (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03232.x · Cited by 98
Immunosuppressant Medications and Mortality in Inflammatory Bowel Disease
Lewis, J. D., Gelfand, J. M., Troxel, A. B., Forde, K. A., Newcomb, C. W., Kim, H., Margolis, D. J., & Strom, B. L. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01836.x · Cited by 97
Iannone, A., Ruospo, M., Wong, G., Principi, M., Barone, M., Strippoli, G. F., & Leo, A. D. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.11.021 · Cited by 97
Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease
Fellermann, Steffen, Stein, J. M., et al. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00695.x · Cited by 95
Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease
Renna, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9675 · Cited by 95
INTERNATIONAL MESALAZINE STUDY GROUP (1990) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1990.tb00449.x · Cited by 94
Church, P. C., Turner, D., Feldman, B. M., Walters, T. D., Greer, M., Amitai, M., Griffiths, A. M., & the ImageKids Study Group (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13024 · Cited by 91
Caprilli, R., Cottone, M., Tonelli, F., Sturniolo, G. C., Castiglione, F., Annese, V., Papi, C., Viscido, A., Cammà, C., Corrao, G., et al. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01462.x · Cited by 91
Surveillance colonoscopy in ulcerative colitis: magnifying chromoendoscopy in the spotlight
Kießlich, R., & Neurath, M. F. (2004) · Gut · doi:10.1136/gut.2003.026351 · Cited by 91
Turner, D., Mack, D. R., Hyams, J. S., LeLeiko, N. S., Otley, A. R., Markowitz, J. F., Kasirer, Y. M., Muise, A. M., Seow, C. H., Silverberg, M. S., et al. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.05.003 · Cited by 90
Tabibian, A., Tabibian, J. H., Beckman, L. J., Raffals, L. L., Papadakis, K. A., & Kane, S. V. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3471-1 · Cited by 89
Methotrexate for maintenance of remission in ulcerative colitis
Wang, Y., MacDonald, J. K., Vandermeer, B., Griffiths, A. M., & El‐Matary, W. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007560.pub3 · Cited by 89
Assche, G. V., Lewis, J. D., Lichtenstein, G. R., Loftus, E. V., Ouyang, Q., Panés, J., Siegel, C. A., Sandborn, W. J., Travis, S. P. L., & Colombel, J. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.211 · Cited by 86
Self-citationvan der Sloot, K. W. J., Joshi, A. D., Bellavance, D. R., Gilpin, K. K., Stewart, K. O., Lochhead, P. J., Garber, J. J., Giallourakis, C. C., Yajnik, V., Ananthakrishnan, A. N., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000978 · Cited by 85
Sandborn, W. J., Feagan, B. G., Panés, J., D’Haens, G., Colombel, J., Zhou, Q., Huang, B., Enejosa, J., Pangan, A. L., & Lacerda, A. P. (2017) · Gastroenterology · doi:10.1016/s0016-5085(17)34357-3 · Cited by 85
The natural history of Crohn’s disease in children: a review of population-based studies
Ďuricová, D., Fumery, M., Annese, V., Lakatos, P. L., Peyrin‐Biroulet, L., & Gower‐Rousseau, C. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000761 · Cited by 84
Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients
Aguas, M. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i32.4391 · Cited by 83
Role of genetics in the diagnosis and prognosis of Crohn's disease
Tsianos, E. V. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i2.105 · Cited by 82
Operative Management of Small Bowel Crohn's Disease
Gardiner, K. R., & Dasari, B. V. M. (2007) · Surgical Clinics of North America · doi:10.1016/j.suc.2007.03.011 · Cited by 80
Budesonide as maintenance treatment in Crohn's disease: a placebo‐controlled trial
Hanauer, S. B., Sandborn, W. J., Persson, A., & Persson, T. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02338.x · Cited by 80
Emerging biologics in inflammatory bowel disease
Chan, H. C.-H., & Ng, S. C. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1283-0 · Cited by 79
Kawalec, P., Mikrut, A., Wiśniewska, N., & Pilc, A. (2013) · Archives of Medical Science · doi:10.5114/aoms.2013.38670 · Cited by 78
Mesalamine and relapse prevention in Crohn's disease
Cottone, M., & Cammà, C. (2000) · Gastroenterology · doi:10.1053/gast.2000.16153 · Cited by 77
Sorrentino, D. R., Terrosu, G., Paviotti, A., Geraci, M., Avellini, C., Zoli, G., Fries, W., Danese, S., Occhipinti, P., Croatto, T., et al. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-2025-z · Cited by 77
Gasia, M. F., Ghosh, S. K., Panaccione, R., Ferraz, J. G., Kaplan, G. G., Leung, Y., Novak, K. L., Seow, C. H., & Iacucci, M. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.12.047 · Cited by 77
Chang, M.-H., Chou, J., Chen, S.-M., TSAI, M.-C., SUN, Y.-S., Lin, C.-C., & Lin, C.-P. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2180 · Cited by 75
Nguyen, D. L., Sandborn, W. J., Loftus, E. V., Larson, D. W., Fletcher, J. G., Becker, B. D., Mandrekar, J. N., Harmsen, W. S., & Bruining, D. H. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.11.023 · Cited by 75
Self-citationOral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance
Ierardi, E., Principi, M., Francavilla, R., Pisani, A. R., Rendina, M. G., Ingrosso, M., Guglielmi, F. W., Pañella, C., & Francavilla, A. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00938.x · Cited by 74
Takenaka, K., Ohtsuka, K., Kitazume, Y., Nagahori, M., Fujii, T., Saito, E., Fujioka, T., Matsuoka, K., Naganuma, M., & Watanabe, M. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000449 · Cited by 71
Kuenzig, M. E., Lee, S., Eksteen, B., Seow, C. H., Barnabe, C. C. M., Panaccione, R., & Kaplan, G. G. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0555-8 · Cited by 68
Ferreiro‐Iglesias, R., Acosta, M. B., Otero-Santiago, M., González, A. L., de la Peña, C. A., Benítez, A., & Domínguez‐Muñoz, J. E. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000312 · Cited by 67
Quality improvement in inflammatory bowel disease.
MELMED, G. Y., & Siegel, C. A. (2013) · Europe PMC (PubMed Central) · Cited by 66
Kennedy, N. A., Clark, A., Walkden, A., Chang, J., Fascì-Spurio, F., Muscat, M., Gordon, B. W., Kingstone, K., Satsangi, J., Arnott, I. D., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.07.005 · Cited by 66
Association Between Affective-Cognitive Symptoms of Depression and Exacerbation of Crohn’s Disease
Gaines, L. S., Slaughter, J. C., Horst, S., Schwartz, D. A., Beaulieu, D. B., Haman, K., Wang, L., Martin, C. F., Long, M. D., Sandler, R. S., et al. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.98 · Cited by 66
Patient Reported Outcome Measures (PROMs) in Inflammatory Bowel Disease: New Data
Bojic, D., Bodger, K., & Travis, S. P. L. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw187 · Cited by 65
Allez, M. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)03970-9 · Cited by 65
CT and MR enterography in Crohn’s disease: current and future applications
Bruining, D. H., Bhatnagar, G., Rimola, J., Taylor, S. A., Zimmermann, E. M., & Fletcher, J. G. (2015) · Abdominal Imaging · doi:10.1007/s00261-015-0360-9 · Cited by 63
Marion, J. F., Waye, J. D., Israel, Y., Present, D. H., Suprun, M., Bodian, C., Harpaz, N., Chapman, M. L., Itzkowitz, S. H., Abreu, M. T., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.11.011 · Cited by 62
Nuti, F., Civitelli, F. S., Bloise, S., Oliva, S., Aloi, M., Torre, G. L., Viola, F., & Cucchiara, S. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv126 · Cited by 61
Efficacy and Safety of Natalizumab and Vedolizumab for the Management of Crohnʼs Disease
Chandar, A. K., Singh, S., Murad, M. H., Peyrin‐Biroulet, L., & Loftus, E. V. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000373 · Cited by 54
Self-citationde Franchis, R., Omodei, P., Ranzi, T., Brignola, C., ROCCA, R., Prada, A., Pera, A., Vecchi, M. L., Piano, M. D., Ferrara, A. M., et al. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00212.x · Cited by 51
Antibiotic Use and the Risk of Flare of Inflammatory Bowel Disease
Aberra, F. N., Brensinger, C. M., Bilker, W. B., Lichtenstein, G. R., & Lewis, J. D. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00020-0 · Cited by 51
Self-citationSeiderer, J., Herrmann, K. A., Diepolder, H. M., Schoenberg, S. O., Wagner, A. C. C., Göke, B., Ochsenkühn, T., & Schäfer, C. (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701397867 · Cited by 51
Prevention of postoperative recurrence of Crohn's disease
van Loo, E. S., Dijkstra, G. D. H., Ploeg, R. J., & Nieuwenhuijs, V. B. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.12.006 · Cited by 51
Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease
Voudoukis, E., Κarmiris, K., Oustamanolakis, P., Theodoropoulou, A., Sfiridaki, A., Paspatis, G. A., & Κoutroubakis, I. E. (2013) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328363e354 · Cited by 47
Dubinsky, M. C., Kugathasan, S., Kwon, S., Haritunians, T., Wrobel, I. T., Wahbeh, G. T., Quiros, A., Bahar, R., Silber, G. H., Farrior, S., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f275 · Cited by 45
Guidelines for Video Capsule Endoscopy: Emphasis on Crohn's Disease
Park, S., Ye, B. D., Kim, K. O., Park, C. H., Lee, W., Jang, B. I., Jeen, Y. T., Choi, M., Kim, H. J., & The Korean Gut Image Study Group (2015) · Clinical Endoscopy · doi:10.5946/ce.2015.48.2.128 · Cited by 44
Prevention of postoperative recurrence of Crohn’s disease by Adalimumab
Savarino, E. V., Dulbecco, P., Bodini, G., et al. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283500849 · Cited by 42
Advanced endoscopic imaging techniques in Crohn's disease
Tontini, G. E., Vecchi, M. L., Neurath, M. F., & Neumann, H. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.09.004 · Cited by 42
Enteral nutrition for maintenance of remission in Crohn's disease
Akobeng, A., & Thomas, A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005984 · Cited by 41
Pathogenesis of Clostridium difficile Infection and Its Potential Role in Inflammatory Bowel Disease
Monaghan, T. M., Cockayne, A., & Mahida, Y. R. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000461 · Cited by 38
Genetic Determinants Associated With Early Age of Diagnosis of IBD
Connelly, T. M., Berg, A. S., Harris, L., Brinton, D. L., Deiling, S. M., & Koltun, W. A. (2015) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000000274 · Cited by 38
Lichtenstein, G. R., & McGovern, D. P. B. (2016) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgs.2016.17 · Cited by 37
Self-citationEffect of 2 Psychotherapies on Depression and Disease Activity in Pediatric Crohnʼs Disease
Szigethy, E., Youk, A. O., Gonzalez-Heydrich, J., Bujoreanu, S. I., Weisz, J., Fairclough, D., Ducharme, P., Jones, N., Lotrich, F., Keljo, D., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000358 · Cited by 34
Feagan, B. G., Sandborn, W. J., Baker, J. P., Cominelli, F., Sutherland, L. R., Elson, C. O., Salzberg, B. A., Archambault, A., Bernstein, C. N., Lichtenstein, G. R., et al. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02336.x · Cited by 34
Self-citationBudesonide for maintenance of remission in Crohn's disease
Simms, L., & Steinhart, A. H. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002913 · Cited by 32
Steinhart, A. H., Forbes, A., MILLS, E. C., Rodgers‐Gray, B. S., & Travis, S. P. L. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03324.x · Cited by 30
Quality Improvement in Inflammatory Bowel Disease
Colletti, R. B., Kappelman, M. D., Crandall, W., & Margolis, P. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5061-0_50 · Cited by 29
Yamamoto, T., Bamba, T., Umegae, S., & Matsumoto, K. (2013) · United European Gastroenterology Journal · doi:10.1177/2050640613495197 · Cited by 29
C-reactive protein in Crohn’s disease: how informative is it?
Magro, F., Sousa, P., & Ministro, P. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.893821 · Cited by 28
Sauter, B. V., Beglinger, C., Girardin, M., Macpherson, A. J., Michetti, P., Schoepfer, A. M., Seibold, F., Vavricka, S. R., & Rogler, G. (2014) · Digestion · doi:10.1159/000360283 · Cited by 25
Cumulative Length of Bowel Resection in a Population-Based Cohort of Patients With Crohn’s Disease
Peyrin‐Biroulet, L., Harmsen, W. S., Tremaine, W. J., Zinsmeister, A. R., Sandborn, W. J., & Loftus, E. V. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.04.031 · Cited by 17
Self-citationUpdate on Therapeutic Drug Monitoring in Crohn's Disease
Heron, V., & Afif, W. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.05.014 · Cited by 14
Shen, F., Zhang, H.-J., Zhao, X.-D., Cao, R., & Shi, R.-H. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02965.x · Cited by 13
The diagnostic usefulness of fecal lactoferrin in the assessment of Crohn's disease activity
Klimczak, K., Łykowska‐Szuber, L., Eder, P., Krela‐Kaźmierczak, I., Stawczyk‐Eder, K., Szymczak‐Tomczak, A., Michalak, M., Studniarek, A., & Linke, K. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.06.015 · Cited by 12
Lee, H., Oh, H., Yang, S., Baek, J., Jung, S., Hong, M., Kim, K. M., Shin, H. D., Kim, K. J., Park, S. H., et al. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx023 · Cited by 10
Liu, Z., & Shen, B. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1068121 · Cited by 5
Cited by
ECCO guidelines on therapeutics in Crohn's disease: medical treatment
Torres, J., Bonovas, S., Doherty, G., Kucharzik, T., Gisbert, J. P., Raine, T., Adamina, M., Armuzzi, A., Bachmann, O., Bager, P., et al. (2020) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjz180 · Cited by 1,374
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
Adamina, M., Bonovas, S., Raine, T., Spinelli, A., Warusavitarne, J., Armuzzi, A., Bachmann, O., Bager, P., Biancone, L., Bokemeyer, B., et al. (2020) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjz187 · Cited by 1,106
The microbiome and inflammatory bowel disease
Glassner, K. L., Abraham, B. P., & Quigley, E. M. M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.11.003 · Cited by 837
Evidence-based clinical practice guidelines for inflammatory bowel disease
Matsuoka, K., Kobayashi, T., Ueno, F., Matsui, T., Hirai, F., Inoue, N., Kato, J., Kobayashi, K., Kobayashi, K., Koganei, K., et al. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1439-1 · Cited by 698
Ward, M. M., Deodhar, A., Gensler, L. S., Dubreuil, M., Yu, D., Khan, M. A., Haroon, N., Borenstein, D., Wang, R., Biehl, A., et al. (2019) · Arthritis Care & Research · doi:10.1002/acr.24025 · Cited by 693
Metadata
- Authors
- Lichtenstein, G. R., Loftus, E. V., Isaacs, K. L., Regueiro, M. D., Gerson, L. B., & Sands, B. E.
- Venue
- American Journal of Gastroenterology
- Published
- 2018-04
- Volume
- 113
- Issue
- 4
- Pages
- 481-517
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2794595980
- Cited by
- 1,421
- References
- 312
- FWCI
- 75.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.